Genmab - ADR XNAS: GMAB

Strong Performer, Getting Expensive

Download real time

31.80 1.13 (3.68%)

New 52W High today

2.7M

XNAS Volume

XNAS 01 Oct, 2025 3:28 PM (EDT)

0.0

Beta 1Year

Very Low volatility

Acquisition

Genmab to acquire Merus N.V. in an $8 billion all-cash deal to expand its oncology pipeline See details

Genmab - ADR RSI, Moving Averages, Technical Analysis MACD, MFI, Stochastic and Candlesticks

Genmab ADR technical analysis - SMA, EMA, Price Change analysis, 52 Week high low, Beta and volume delivery analysis